Chorokbaem Healthcare Co Ltd (118000) - Total Liabilities
Based on the latest financial reports, Chorokbaem Healthcare Co Ltd (118000) has total liabilities worth ₩106.27 Billion KRW (≈ $72.02 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Chorokbaem Healthcare Co Ltd (118000) investment intensity to see how much of total assets are deployed in long-term investments.
Chorokbaem Healthcare Co Ltd - Total Liabilities Trend (2013–2025)
This chart illustrates how Chorokbaem Healthcare Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 118000 total assets.
Chorokbaem Healthcare Co Ltd Competitors by Total Liabilities
The table below lists competitors of Chorokbaem Healthcare Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PT Cilacap Samudera Fishing Industry Tbk
JK:ASHA
|
Indonesia | Rp32.64 Billion |
|
CTRL Group Limited Ordinary Shares
NASDAQ:MCTR
|
USA | $11.92 Million |
|
TCS Group Holdings Bhd
KLSE:0221
|
Malaysia | RM209.67 Million |
|
Dantax
CO:DANT
|
Denmark | Dkr5.84 Million |
|
BTC Health Ltd
AU:BTC
|
Australia | AU$248.95K |
|
Megapolitan Developments Tbk
JK:EMDE
|
Indonesia | Rp1.23 Trillion |
|
NexturnBioscience Co. Ltd
KQ:089140
|
Korea | ₩128.65 Billion |
|
Innodep Inc.
KQ:303530
|
Korea | ₩38.83 Billion |
Liability Composition Analysis (2013–2025)
This chart breaks down Chorokbaem Healthcare Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Chorokbaem Healthcare Co Ltd to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.48 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.85 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.44 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Chorokbaem Healthcare Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Chorokbaem Healthcare Co Ltd (2013–2025)
The table below shows the annual total liabilities of Chorokbaem Healthcare Co Ltd from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩76.98 Billion ≈ $52.17 Million |
+87.67% |
| 2024-12-31 | ₩41.02 Billion ≈ $27.80 Million |
+133.08% |
| 2023-12-31 | ₩17.60 Billion ≈ $11.93 Million |
-70.80% |
| 2022-12-31 | ₩60.28 Billion ≈ $40.85 Million |
+5.93% |
| 2021-12-31 | ₩56.90 Billion ≈ $38.56 Million |
-8.47% |
| 2020-12-31 | ₩62.17 Billion ≈ $42.13 Million |
+83.55% |
| 2019-12-31 | ₩33.87 Billion ≈ $22.95 Million |
-21.10% |
| 2018-12-31 | ₩42.93 Billion ≈ $29.09 Million |
+138.07% |
| 2017-12-31 | ₩18.03 Billion ≈ $12.22 Million |
+17.03% |
| 2016-12-31 | ₩15.41 Billion ≈ $10.44 Million |
+50.77% |
| 2015-12-31 | ₩10.22 Billion ≈ $6.93 Million |
-10.02% |
| 2014-12-31 | ₩11.36 Billion ≈ $7.70 Million |
+91.74% |
| 2013-12-31 | ₩5.92 Billion ≈ $4.01 Million |
-- |
About Chorokbaem Healthcare Co Ltd
METACARE CO., Ltd. distributes pharmaceuticals and medical devices in South Korea. The company sells orthopedic medical devices and consumables; and provides pharmaceutical integration and professional logistics services. It is involved in investment advisory. The company was formerly known as SMEDI Co., Ltd. and changed its name to METACARE CO., Ltd. in August 2024. METACARE CO., Ltd. was founde… Read more